Class B scavenger receptor types I and II and CD36 targeting improves sepsis survival and acute outcomes in mice

Journal of Immunology

Volumn 188, Issue 6, 2012, Pages 2749-2758

  Leelahavanichkul, Asada ^a,b   Bocharov, Alexander V ^c   Kurlander, Roger ^c   Baranova, Irina N ^c   Vishnyakova, Tatyana G ^c   Souza, Ana C P ^a   Hu, Xuzhen ^a   Doi, Kent ^a   Vaisman, Boris ^d   Amar, Marcelo ^d   Sviridov, Denis ^d   Chen, Zhigang ^c   Remaley, Alan T ^d   Csako, Gyorgy ^c   Patterson, Amy P ^c   Yuen, Peter S T ^a   Star, Robert A ^a   Eggerman, Thomas L ^a,c  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b CHULALONGKORN UNIVERSITY   (Thailand)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD36 ANTIGEN; CILASTATIN PLUS IMIPENEM; DEXAMETHASONE; FLUDROCORTISONE ACETATE; INTERLEUKIN 10; INTERLEUKIN 6; PEPTIDE L 37PA; POLYPEPTIDE ANTIBIOTIC AGENT; SCAVENGER RECEPTOR B; SCAVENGER RECEPTOR B TYPE 2; SCAVENGER RECEPTOR BI; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC THERAPY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BACTERIAL COUNT; CELL SURVIVAL; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXICITY; DRUG TARGETING; HUMAN; HUMAN CELL; KIDNEY FUNCTION; MOUSE; MULTIPLE ORGAN FAILURE; NONHUMAN; OUTCOME ASSESSMENT; PHAGOCYTE; PRIORITY JOURNAL; PROTEIN TARGETING; RISK REDUCTION; SEPSIS; SURVIVAL RATE; WILD TYPE;

ANIMALS; ANTIGENS, CD36; DISEASE MODELS, ANIMAL; GRANULOCYTES; INFLAMMATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROSCOPY, CONFOCAL; PHAGOCYTOSIS; SCAVENGER RECEPTORS, CLASS B; SEPSIS;

EID: 84863287292     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1003445     Document Type: Article

References (51)

1. Angus, D. C. 2007. Caring for the critically ill patient: challenges and opportunities. JAMA 298: 456-458. (Pubitemid 47124067)
2. Angus, D. C., W. T. Linde-Zwirble, J. Lidicker, G. Clermont, J. Carcillo, and M. R. Pinsky. 2001. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit. Care Med. 29: 1303-1310. (Pubitemid 32641789)
3. Martin, G. S., D. M. Mannino, S. Eaton, and M. Moss. 2003. The epidemiology of sepsis in the United States from 1979 through 2000. N. Engl. J. Med. 348: 1546-1554. (Pubitemid 36437931)
4. Sessler, C. N., J. C. Perry, and K. L. Varney. 2004. Management of severe sepsis and septic shock. Curr. Opin. Crit. Care 10: 354-363. (Pubitemid 39313504)
5. Dellinger, R. P., J. F. Tomayko, D. C. Angus, S. Opal, M. A. Cupo, S. McDermott, A. Ducher, T. Calandra, and J. Cohen; Lipid Infusion and Patient Outcomes in Sepsis (LIPOS) Investigators. 2009. Efficacy and safety of a phospholipid emulsion (GR270773) in Gram-negative severe sepsis: results of a phase II multicenter, randomized, placebo-controlled, dose-finding clinical trial. Crit. Care Med. 37: 2929-2938.
6. Russell, J. A. 2006. Management of sepsis. N. Engl. J. Med. 355: 1699-1713. (Pubitemid 44583960)
7. Schultz, M. J., and T. van der Poll. 2004. Modulation of innate immune responses in the treatment of sepsis and pneumonia. Curr. Drug Targets Inflamm. Allergy 3: 11-17. (Pubitemid 38854886)
8. Hotchkiss, R. S., and I. E. Karl. 2003. The pathophysiology and treatment of sepsis. N. Engl. J. Med. 348: 138-150. (Pubitemid 36056721)
9. Knapp, S., U. Matt, N. Leitinger, and T. van der Poll. 2007. Oxidized phospholipids inhibit phagocytosis and impair outcome in gram-negative sepsis in vivo. J. Immunol. 178: 993-1001. (Pubitemid 46095173)
10. Plitas, G., B. M. Burt, H. M. Nguyen, Z. M. Bamboat, and R. P. DeMatteo. 2008. Toll-like receptor 9 inhibition reduces mortality in polymicrobial sepsis. J. Exp. Med. 205: 1277-1283. (Pubitemid 351831485)
11. Tsujimoto, H., S. Ono, P. A. Efron, P. O. Scumpia, L. L. Moldawer, and H. Mochizuki. 2008. Role of Toll-like receptors in the development of sepsis. Shock 29: 315-321. (Pubitemid 351271701)
12. Opitz, B., J. Eitel, K. Meixenberger, and N. Suttorp. 2009. Role of Toll-like receptors, NOD-like receptors and RIG-I-like receptors in endothelial cells and systemic infections. Thromb. Haemost. 102: 1103-1109.
13. Amiel, E., J. L. Acker, R. M. Collins, and B. Berwin. 2009. Uncoupling scavenger receptor A-mediated phagocytosis of bacteria from endotoxic shock resistance. Infect. Immun. 77: 4567-4573.
14. Dunne, D. W., D. Resnick, J. Greenberg, M. Krieger, and K. A. Joiner. 1994. The type I macrophage scavenger receptor binds to gram-positive bacteria and recognizes lipoteichoic acid. Proc. Natl. Acad. Sci. USA 91: 1863-1867. (Pubitemid 24080306)
15. Peiser, L., M. P. De Winther, K. Makepeace, M. Hollinshead, P. Coull, J. Plested, T. Kodama, E. R. Moxon, and S. Gordon. 2002. The class A macrophage scavenger receptor is a major pattern recognition receptor for Neisseria meningitidis which is independent of lipopolysaccharide and not required for secretory responses. Infect. Immun. 70: 5346-5354.
16. Peiser, L., K. Makepeace, A. Plüddemann, S. Savino, J. C. Wright, M. Pizza, R. Rappuoli, E. R. Moxon, and S. Gordon. 2006. Identification of Neisseria meningitidis nonlipopolysaccharide ligands for class A macrophage scavenger receptor by using a novel assay. Infect. Immun. 74: 5191-5199. (Pubitemid 44300438)
17. Baranova, I. N., R. Kurlander, A. V. Bocharov, T. G. Vishnyakova, Z. Chen, A. T. Remaley, G. Csako, A. P. Patterson, and T. L. Eggerman. 2008. Role of human CD36 in bacterial recognition, phagocytosis, and pathogen-induced JNK-mediated signaling. J. Immunol. 181: 7147-7156.
18. Bocharov, A. V., I. N. Baranova, T. G. Vishnyakova, A. T. Remaley, G. Csako, F. Thomas, A. P. Patterson, and T. L. Eggerman. 2004. Targeting of scavenger receptor class B type I by synthetic amphipathic alpha-helical- containing peptides blocks lipopolysaccharide (LPS) uptake and LPS-induced pro-inflammatory cytokine responses in THP-1 monocyte cells. J. Biol. Chem. 279: 36072-36082. (Pubitemid 39100615)
19. Philips, J. A., E. J. Rubin, and N. Perrimon. 2005. Drosophila RNAi screen reveals CD36 family member required for mycobacterial infection. Science 309: 1251-1253. (Pubitemid 41170920)
20. Vishnyakova, T. G., A. V. Bocharov, I. N. Baranova, Z. Chen, A. T. Remaley, G. Csako, T. L. Eggerman, and A. P. Patterson. 2003. Binding and internalization of lipopolysaccharide by Cla-1, a human orthologue of rodent scavenger receptor B1. J. Biol. Chem. 278: 22771-22780. (Pubitemid 36830338)
21. Vishnyakova, T. G., R. Kurlander, A. V. Bocharov, I. N. Baranova, Z. Chen, M. S. Abu-Asab, M. Tsokos, D. Malide, F. Basso, A. Remaley, et al. 2006. CLA-1 and its splicing variant CLA-2 mediate bacterial adhesion and cytosolic bacterial invasion in mammalian cells. Proc. Natl. Acad. Sci. USA 103: 16888-16893. (Pubitemid 44737348)
22. Stewart, C. R., L. M. Stuart, K. Wilkinson, J. M. van Gils, J. Deng, A. Halle, K. J. Rayner, L. Boyer, R. Zhong, W. A. Frazier, et al. 2010. CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer. Nat. Immunol. 11: 155-161.
23. Baranova, I. N., T. G. Vishnyakova, A. V. Bocharov, R. Kurlander, Z. Chen, M. L. Kimelman, A. T. Remaley, G. Csako, F. Thomas, T. L. Eggerman, and A. P. Patterson. 2005. Serum amyloid A binding to CLA-1 (CD36 and LIMPII analogous-1) mediates serum amyloid A protein-induced activation of ERK1/2 and p38 mitogen-activated protein kinases. J. Biol. Chem. 280: 8031-8040. (Pubitemid 40349701)
24. Moore, K. J., J. El Khoury, L. A. Medeiros, K. Terada, C. Geula, A. D. Luster, and M. W. Freeman. 2002. A CD36-initiated signaling cascade mediates inflammatory effects of beta-amyloid. J. Biol. Chem. 277: 47373-47379. (Pubitemid 36163374)
25. Rahaman, S. O., D. J. Lennon, M. Febbraio, E. A. Podrez, S. L. Hazen, and R. L. Silverstein. 2006. A CD36-dependent signaling cascade is necessary for macrophage foam cell formation. Cell Metab. 4: 211-221. (Pubitemid 44283954)
26. Williams, D. L., M. de La Llera-Moya, S. T. Thuahnai, S. Lund-Katz, M. A. Connelly, S. Azhar, G. M. Anantharamaiah, and M. C. Phillips. 2000. Binding and cross-linking studies show that scavenger receptor BI interacts with multiple sites in apolipoprotein A-I and identify the class A amphipathic alpha-helix as a recognition motif. J. Biol. Chem. 275: 18897-18904.
27. Dear, J. W., H. Yasuda, X. Hu, S. Hieny, P. S. Yuen, S. M. Hewitt, A. Sher, and R. A. Star. 2006. Sepsis-induced organ failure is mediated by different pathways in the kidney and liver: acute renal failure is dependent on MyD88 but not renal cell apoptosis. Kidney Int. 69: 832-836.
28. Miyaji, T., X. Hu, P. S. Yuen, Y. Muramatsu, S. Iyer, S. M. Hewitt, and R. A. Star. 2003. Ethyl pyruvate decreases sepsis-induced acute renal failure and multiple organ damage in aged mice. Kidney Int. 64: 1620-1631. (Pubitemid 37323689)
29. Doi, K., X. Hu, P. S. Yuen, A. Leelahavanichkul, H. Yasuda, S. M. Kim, J. Schnermann, T. E. Jonassen, J. Frøkiaer, S. Nielsen, and R. A. Star. 2008. AP214, an analogue of alpha-melanocyte-stimulating hormone, ameliorates sepsis-induced acute kidney injury and mortality. Kidney Int. 73: 1266-1274. (Pubitemid 351693164)
30. Leelahavanichkul, A., H. Yasuda, K. Doi, X. Hu, H. Zhou, P. S. Yuen, and R. A. Star. 2008. Methyl-2-acetamidoacrylate, an ethyl pyruvate analog, decreases sepsis-induced acute kidney injury in mice. Am. J. Physiol. Renal Physiol. 295: F1825-F1835.
31. Németh, K., A. Leelahavanichkul, P. S. Yuen, B. Mayer, A. Parmelee, K. Doi, P. G. Robey, K. Leelahavanichkul, B. H. Koller, J. M. Brown, et al. 2009. Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat. Med. 15: 42-49.
32. Yasuda, H., A. Leelahavanichkul, S. Tsunoda, J. W. Dear, Y. Takahashi, S. Ito, X. Hu, H. Zhou, K. Doi, R. Childs, et al. 2008. Chloroquine and inhibition of Toll-like receptor 9 protect from sepsis-induced acute kidney injury. Am. J. Physiol. Renal Physiol. 294: F1050-F1058.
33. Yasuda, H., P. S. Yuen, X. Hu, H. Zhou, and R. A. Star. 2006. Simvastatin improves sepsis-induced mortality and acute kidney injury via renal vascular effects. Kidney Int. 69: 1535-1542.
34. Baranova, I. N., T. G. Vishnyakova, A. V. Bocharov, A. Leelahavanichkul, R. Kurlander, Z. Chen, A. C. Souza, P. S.Yuen, R. A. Star, G. Csako, A. P. Patterson, et al. 2012. Class B scavenger receptor types I and II and CD36 mediate bacterial recognition and proinflammatory signaling induced by Escherichia coli, lipopolysaccharide, and cytosolic chaperonin 60. J. Immunol. 188: 1371-1380.
35. Yuen, P. S., S. R. Dunn, T. Miyaji, H. Yasuda, K. Sharma, and R. A. Star. 2004. A simplified method for HPLC determination of creatinine in mouse serum. Am. J. Physiol. Renal Physiol. 286: F1116-F1119. (Pubitemid 38656367)
36. Stuart, L. M., J. Deng, J. M. Silver, K. Takahashi, A. A. Tseng, E. J. Hennessy, R. A. Ezekowitz, and K. J. Moore. 2005. Response to Staphylococcus aureus requires CD36-mediated phagocytosis triggered by the COOH-terminal cytoplasmic domain. J. Cell Biol. 170: 477-485. (Pubitemid 41126946)
37. Cai, L., A. Ji, F. C. de Beer, L. R. Tannock, and D. R. van der Westhuyzen. 2008. SR-BI protects against endotoxemia in mice through its roles in glucocorticoid production and hepatic clearance. J. Clin. Invest. 118: 364-375.
38. Guo, L., Z. Song, M. Li, Q. Wu, D. Wang, H. Feng, P. Bernard, A. Daugherty, B. Huang, and X. A. Li. 2009. Scavenger Receptor BI Protects against Septic Death through Its Role in Modulating Inflammatory Response. J. Biol. Chem. 284: 19826-19834.
39. Hoekstra, M., I. Meurs, M. Koenders, R. Out, R. B. Hildebrand, J. K. Kruijt, M. Van Eck, and T. J. Van Berkel. 2008. Absence of HDL cholesteryl ester uptake in mice via SR-BI impairs an adequate adrenal glucocorticoid-mediated stress response to fasting. J. Lipid Res. 49: 738-745.
40. Hoekstra, M., D. Ye, R. B. Hildebrand, Y. Zhao, B. Lammers, M. Stitzinger, J. Kuiper, T. J. Van Berkel, and M. Van Eck. 2009. Scavenger receptor class B type I-mediated uptake of serum cholesterol is essential for optimal adrenal glucocorticoid production. J. Lipid Res. 50: 1039-1046.
41. Podrez, E. A., T. V. Byzova, M. Febbraio, R. G. Salomon, Y. Ma, M. Valiyaveettil, E. Poliakov, M. Sun, P. J. Finton, B. R. Curtis, et al. 2007. Platelet CD36 links hyperlipidemia, oxidant stress and a prothrombotic phenotype. Nat. Med. 13: 1086-1095. (Pubitemid 47517507)
42. Gupta, H., L. Dai, G. Datta, D. W. Garber, H. Grenett, Y. Li, V. Mishra, M. N. Palgunachari, S. Handattu, S. H. Gianturco, et al. 2005. Inhibition of lipopolysaccharide-induced inflammatory responses by an apolipoprotein AI mimetic peptide. Circ. Res. 97: 236-243. (Pubitemid 41105449)
43. Levine, D. M., T. S. Parker, T. M. Donnelly, A. Walsh, and A. L. Rubin. 1993. In vivo protection against endotoxin by plasma high density lipoprotein. Proc. Natl. Acad. Sci. USA 90: 12040-12044. (Pubitemid 24008776)
44. Zhang, Z., G. Datta, Y. Zhang, A. P. Miller, P. Mochon, Y. F. Chen, J. Chatham, G. M. Anantharamaiah, and C. R. White. 2009. Apolipoprotein A-I mimetic peptide treatment inhibits inflammatory responses and improves survival in septic rats. Am. J. Physiol. Heart Circ. Physiol. 297: H866-H873.
45. Doi, K., A. Leelahavanichkul, P. S. Yuen, and R. A. Star. 2009. Animal models of sepsis and sepsis-induced kidney injury. J. Clin. Invest. 119: 2868-2878.
46. Turnbull, I. R., A. T. Clark, P. E. Stromberg, D. J. Dixon, C. A. Woolsey, C. G. Davis, R. S. Hotchkiss, T. G. Buchman, and C. M. Coopersmith. 2009. Effects of aging on the immunopathologic response to sepsis. Crit. Care Med. 37: 1018-1023.
47. Alves-Filho, J. C., C. Benjamim, B. M. Tavares-Murta, and F. Q. Cunha. 2005. Failure of neutrophil migration toward infectious focus in severe sepsis: a critical event for the outcome of this syndrome. Mem. Inst. Oswaldo Cruz 100(Suppl. 1): 223-226. (Pubitemid 40685468)
48. Alves-Filho, J. C., A. de Freitas, F. Spiller, F. O. Souto, and F. Q. Cunha. 2008. The role of neutrophils in severe sepsis. Shock 30(Suppl. 1): 3-9.
49. Triantafilou, M., F. G. Gamper, R. M. Haston, M. A. Mouratis, S. Morath, T. Hartung, and K. Triantafilou. 2006. Membrane sorting of toll-like receptor (TLR)-2/6 and TLR2/1 heterodimers at the cell surface determines heterotypic associations with CD36 and intracellular targeting. J. Biol. Chem. 281: 31002-31011. (Pubitemid 44582155)
50. Baranova, I. N., A. V. Bocharov, T. G. Vishnyakova, R. Kurlander, Z. Chen, D. Fu, I. M. Arias, G. Csako, A. P. Patterson, and T. L. Eggerman. 2010. CD36 is a novel serum amyloid A (SAA) receptor mediating SAA binding and SAA-induced signaling in human and rodent cells. J. Biol. Chem. 285: 8492-8506.
51. Stearns-Kurosawa, D. J., M. F. Osuchowski, C. Valentine, S. Kurosawa, and D. G. Remick. 2011. The pathogenesis of sepsis. Annu. Rev. Pathol. 6: 19-48.